Pure Global

Thyroxine-binding Globulin - India CDSCO Medical Device Registration

Thyroxine-binding Globulin is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2022/000117_e4bce60e81ee0abc32743c730eff04c6_3080c7744c62bb704935a77fb04bcb00. This device is marketed under the brand name eCLIA. The license holder is Q-Line Biotech Private Limited (Formerly Known As POCT SERVICES PRIVATE LIMITED), and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class C
Thyroxine-binding Globulin
UID: IMP/IVD/2022/000117_e4bce60e81ee0abc32743c730eff04c6_3080c7744c62bb704935a77fb04bcb00

Brand Name

eCLIA

Device Class

Class C

Approving Authority

CDSCO

Product Information

Immunoassay for in vitro quantitative determination of Thyroxine-binding Globulin (eCLIA) in human serum and plasma. The results can be used in assisting diagnosis of thyroid diseases.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing